M. Robinson, K. Vervier, Simon Harris, A. Popple, D. Klisko, Robyn Hudson, G. Bakdash, Laure Castan, C. Villemin, David John Adams, Doreen Milne, C. Booth, C. Parkinson, R. Rabbie, S. Welsh, E. Barker, K. Dalchau, P. Corrie, T. Lawley
{"title":"摘要P074: MB097:一种由免疫检查点抑制剂患者的精确微生物组谱临床定义的治疗性细菌联合体,在体外和体内具有强大的抗肿瘤功效","authors":"M. Robinson, K. Vervier, Simon Harris, A. Popple, D. Klisko, Robyn Hudson, G. Bakdash, Laure Castan, C. Villemin, David John Adams, Doreen Milne, C. Booth, C. Parkinson, R. Rabbie, S. Welsh, E. Barker, K. Dalchau, P. Corrie, T. Lawley","doi":"10.1158/2326-6074.tumimm21-p074","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":120683,"journal":{"name":"Other Topics","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Abstract P074: MB097: A therapeutic consortium of bacteria clinically-defined by precision microbiome profiling of immune checkpoint inhibitor patients with potent anti-tumor efficacy in vitro and in vivo\",\"authors\":\"M. Robinson, K. Vervier, Simon Harris, A. Popple, D. Klisko, Robyn Hudson, G. Bakdash, Laure Castan, C. Villemin, David John Adams, Doreen Milne, C. Booth, C. Parkinson, R. Rabbie, S. Welsh, E. Barker, K. Dalchau, P. Corrie, T. Lawley\",\"doi\":\"10.1158/2326-6074.tumimm21-p074\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":120683,\"journal\":{\"name\":\"Other Topics\",\"volume\":\"1 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Other Topics\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1158/2326-6074.tumimm21-p074\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Other Topics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1158/2326-6074.tumimm21-p074","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Abstract P074: MB097: A therapeutic consortium of bacteria clinically-defined by precision microbiome profiling of immune checkpoint inhibitor patients with potent anti-tumor efficacy in vitro and in vivo